News

Jean-Ehrland Ricci: ”We investigate how targeting glycolysis may influence immune response anti-cancer”

The researcher at INSERM (French Institute for Health and Medical Research) Jean-Ehrland Ricci examines the correlation between glycolysis, cell death and immune response in tumor cells. He explained his latest developments in his research on IDIBELL seminar series November 18. Most cancer cells exhibit increased glycolysis for the generation of their energy supply (named the […]

Leer más about Jean-Ehrland Ricci: ”We investigate how targeting glycolysis may influence immune response anti-cancer”

DNA in my pocket

Some forty secondary and high school students of L’Hospitalet have had the opportunity to discover the research of IDIBELL during activities that the center has prepared to celebrate the Week of Science. As if they were real scientists, students carried out an experiment that they can easily repeat at home. They extracted their DNA, their […]

Leer más about DNA in my pocket

Described a new molecular mechanism altered in breast cancer development

About 10% of breast cancers are due to mutations in genes called BRCA1 and BRCA2. Still, it is not yet fully known the molecular mechanism that explains how the alteration of these genes greatly increases the risk of cancer. An international team led by the researcher of the IDIBELL and the Catalan Institute of Oncology […]

Leer más about Described a new molecular mechanism altered in breast cancer development

Louis Bouscail: “Our research in gene therapy must advance step by step. Our next challenge is to reach phase II of our clinical trial”

The gastroenterologist of the University Hospital of Rangueil, Touluse, and researcher at INSERM, Louis Buscail explained his latest advances in gene therapy for advanced pancreatic cancer in IDIBELL seminar series on 11 November. Currently, the only effective treatment for pancreatic cancer is surgery. The chemotherapeutic agent gemcitabine improves the survival of the patient but survival […]

Leer más about Louis Bouscail: “Our research in gene therapy must advance step by step. Our next challenge is to reach phase II of our clinical trial”

La Marató de TV3 finance five projects involving IDIBELL researchers

Five IDIBELL researchers are involved in projects funded by La Marató de TV3, dedicated to spinal cord and acquired brain injuries. They are María Berdasco, research group of Cancer Epigenetics; Artur Llobet, research group of celular and Molecular Neurobiology; Cristina Muñoz Pinedo, head of the research group of Cell Death regulation; Antoni Rodríguez-Fornells, head of […]

Leer más about La Marató de TV3 finance five projects involving IDIBELL researchers

The therapeutic videogame realized by IDIBELL researchers, one of the best ideas of the year for ‘Diario Médico’

The IDIBELL and the University Hospital of Bellvitge have received one of the awards to the Best Ideas of the Year, awarded by the newspaper specializing in medicine and health ‘Diario Médico’, for their therapeutic videogame, called Islands, directed to complement the therapy of patients with eating disorders or pathological gambling addiction. This is the […]

Leer más about The therapeutic videogame realized by IDIBELL researchers, one of the best ideas of the year for ‘Diario Médico’

Ben Lehner: Why would a mutation kill me, but not you?”

This is the big question that drives all the research in the laboratory of Genetic Systems directed by the ICREA researcher Ben Lehner at the Center for Genomic Regulation in Barcelona. Lehner explained their latest findings on an IDIBELL seminar on November 4th. Lehner’s group seeks to understand why two genetically identical individuals, which have […]

Leer más about Ben Lehner: Why would a mutation kill me, but not you?”

IDIBELL brings science to everyone during the Science Week

Between November 7 to 20 the Science Week is is celebrated throughout Europe. This is an initiative that aims to bring the results of scientific research to society. More information at Bellvitge Researches

Leer más about IDIBELL brings science to everyone during the Science Week

High alcohol consumption doubles the risk of gastric cancer

High consumption of alcohol (more than 60 grams per day) significantly increases the risk of gastric cancer. So concludes a study conducted by the Nutrition, Environment and Cancer research Group of the IDIBELL at the Catalan Institute of Oncology that has been published in American Journal of Clinical Nutrition.. The association between alcohol and gastric […]

Leer más about High alcohol consumption doubles the risk of gastric cancer
Scroll to Top